Human genetic studies have emphasised the dominant contribution of 25 pancreatic islet dysfunction to development of Type 2 Diabetes (T2D). However, 26 limited annotation of the islet epigenome has constrained efforts to define the 27 molecular mechanisms mediating the, largely regulatory, signals revealed by 28 Genome-Wide Association Studies (GWAS). We characterised patterns of 29 chromatin accessibility (ATAC-seq, n=17) and DNA methylation (whole-genome 30 bisulphite sequencing, n=10) in human islets, generating high-resolution 31 chromatin state maps through integration with established ChIP-seq marks. We 32 found enrichment of GWAS signals for T2D and fasting glucose was concentrated 33 in subsets of islet enhancers characterised by open chromatin and 34 hypomethylation, with the former annotation predominant. At several loci 35 (including CDC123, ADCY5, KLHDC5) the combination of fine-mapping genetic 36 data and chromatin state enrichment maps, supplemented by allelic imbalance in 37 chromatin accessibility pinpointed likely causal variants. The combination of 38 2 increasingly-precise genetic and islet epigenomic information accelerates 39 definition of causal mechanisms implicated in T2D pathogenesis. 40 41 2013, Pasquali et al. , Gaulton et al., 2010, Varshney et al., 2017. Most 68 importantly, in part due to historical challenges in accessing human islet 69 material or authentic human cellular models, reference annotations of the islet 70 epigenome and transcriptome (in the context of projects such as GTex, ENCODE 71 3 and Epigenome Roadmap) have been largely absent (It is worth noting that islets 72 constitute only ~1% of the pancreas, and islet epigenomes and transcriptomes 73 cannot therefore be reliably assays in analyses involving the entire organ). 74 75 Previous islet epigenome studies have, therefore, had only limited ability to 76 directly relate genetic variation to regulatory performance or to broadly 77 characterise the role of DNA methylation in these processes. 78
Introduction

42
T2D is a complex disease characterised by insulin resistance and reduced beta 43 cell function. Recent GWAS have identified a large number of T2D susceptibility 44 loci (Mahajan et al., 2014 , Morris et al., 2012 , Voight et al., 2010 , the majority of 45 which affect insulin secretion and beta cell function (Dimas et al., 2014 , Wood et 46 al., 2017 . However, most GWAS signals map to the non-coding genome and 47 identification of the molecular mechanisms through which non-coding variants 48 exert their effect has proven challenging. Several studies have demonstrated that 49 T2D-associated variants map disproportionately to regulatory elements, 50 particularly those which influence RNA expression and cellular function of 51 human pancreatic islets. (Parker et al., 2013 , Pasquali et al., 2014 , van de Bunt et 52 al., 2015 , Olsson et al., 2014 , Dayeh et al., 2014 , Volkov et al., 2017 , Varshney et 53 al., 2017 , Gaulton et al., 2015b , Gaulton et al., 2010 . 54 55 Characterisation of the islet regulome has until now been limited in scope. The 56 use of DNA methylation and open chromatin data to further annotate ChIP-seq 57 derived chromatin states has successfully uncovered novel biology for other 58 diseases (Wang et al., 2016) . Existing methylation studies in islets, however, 59 have either profiled a very small proportion of methylation sites using 60 methylation arrays (Olsson et al., 2014 , Dayeh et al., 2014 or focused on T2D-61 associated disease differentially methylated regions (dDMRs) rather than the 62 integration of DNA methylation status with T2D-relevant GWAS data (Volkov et 63 al., 2017) . At the same time, assays of open chromatin in human islets have been 64 restricted to small sample numbers (limiting the potential to capture allelic 65 imbalance in chromatin accessibility for example): these have focussed 66 predominantly on the impact of clustered or "stretch" enhancers (Parker et al., 67 5 chromatin states: the largest differences were observed for weak promoters 138 (median WGBS=0.71 vs. median 450k=0.11, KS test D=0.51, ) and 139 weak enhancers (WGBS=0.87 vs. 450k median=0. 76, D=0.39, P<2.2x10 -16 , 140 Supplementary Figure 1D ). 141
142
In terms of coverage, most chromatin states, apart from promoters, were poorly 143 represented by CpG sites directly interrogated by the array: for example the 144 array assayed only ~2.9% of CpG sites in strong enhancer states (2.7-3.8% 145 depending on strong enhancer subtype, Figure 1C ). Although methylation levels 146
were previously reported to be highly correlated across short (0.1-2kb) genomic 147 distances (Zhang et al., 2015 , Bell et al., 2011 , Eckhardt et al., 2006 , Guo et al., 148 2017 , the observed significant differences in the methylation distribution 149 ( Figure 1C, Supplementary Figure 1D ) across chromatin states including weak 150 promoter (median size 600bp) and enhancer subtypes (median size ranges from 151 200-1200bp) indicate that these correlative effects are not strong enough to 152 counterbalance the low coverage of the 450k array. These findings are consistent 153 with 450k array content being focused towards CpG-dense hypomethylated and 154 permissive promoter regions. This highlights the limited capacity of the array to 155 comprehensively interrogate the global DNA methylome, in particular at distal 156 regulatory states such as enhancers. 157 158 To understand the value of these data to reveal molecular mechanisms at GWAS 159 loci, where we and others had shown enrichment for islet enhancer states 160 (Pasquali et al., 2014 , Gaulton et al., 2015a , Parker et al., 2013 , we were 161 interested to see how the selective coverage of the array might impact on its 162 ability to interrogate methylation in GWAS-identified regions. We used the 163 largest currently available T2D GWAS data set (from the DIAGRAM consortium 164 involving 26.7k cases and 132.5k controls of predominantly European origin, 165 imputed to the 1000G Mar 2012 reference panel) to identify the "credible sets" 166 of variants at each locus which collectively account for 99% of the posterior 167 probability of association (PPA, (Scott et al., 2017 , Maller et al., 2012 ). 168 6 To estimate the respective proportions of these T2D-associated variants 170 captured by CpG sites assayed by the 450k array and WGBS, we determined, for 171 each locus, the combined PPA of all 99% credible set variants mapping within 172 1000bp of any CpG site captured. This is based on evidence that across short 173 distances CpG methylation is highly correlated (Zhang et al., 2015 , Bell et al., 174 2011 , Eckhardt et al., 2006 , Guo et al., 2017 and may be influenced by genetic 175 variants associated with altered transcription factor binding (Do et al., 2016) . We 176 found that coverage of this space of putative T2D GWAS variants by the 450k 177 array is low: across GWAS loci, the combined PPA attributable to variants within 178 regions assayed by the array ranged from 0-99% with a median PPA per locus of 179 16% (compared to a WGBS median PPA per locus=99%, 180 Figure 1D, top) . We estimated that the equivalent figure for a recently developed 181 upgrade of the 450k array, which captures ~850k CpG sites and aims to provide 182 better coverage of enhancer regions, would be ~39% (range 0%-99% Figure 1D , 183 top). For instance, at the DGKB T2D locus (centred on rs10276674), CpG sites 184 covered by the 450k array interrogated less than 1% of the PPA of associated 185 variants (vs. 99% captured by WGBS); the equivalent figure for the 850k array 186 would be 23% ( Figure 1E ). We obtained similar results when we performed 187 equivalent analyses using GWAS data for fasting glucose (FG, from the ENGAGE 188 consortium (Horikoshi et al., 2015) ), another phenotype dominated by islet 189 dysfunction (Figure 1D, bottom). 190 191 These data indicate that available methylation arrays provide poor genome-wide 192 coverage of methylation status and are notably deficient in capturing 193 methylation status around the distal regulatory enhancer regions most relevant 194 to T2D predisposition. For this reason, we focused subsequent analyses on the 195 WGBS data. 196 197
Integration islet methylation and other epigenomic annotations 198 199
Studies in a variety of other tissues have shown that hypomethylation is a strong 200 indicator of regulatory function (Stadler et al., 2011) . More specifically, 201 continuous stretches of CpG-poor Low-Methylated Regions (LMRs, with 202 10 FGWAS to the same sets of large-scale GWAS data for T2D (from DIAGRAM (Scott 302 et al., 2017) ) and FG (ENGAGE (Horikoshi et al., 2015) ) described in section 2.1. 303 FGWAS allowed us to combine GWAS and genomic data to determine the 304 genome-wide enrichment within islet regulatory features for variants associated 305 with T2D risk. These enrichment priors were then used to generate credible 306 variant sets that are informed by both GWAS and genomic data, as described in 307 section 2.4. 308
309
In single-feature analyses, we found significant enrichment (Confidence Interval 310 (CI)>0) limited to four enhancer states (open weak enhancers, both types of 311 strong enhancer and H3K36me3 marked genic enhancers) ( Figure 3B , Table 1 ). 312
To take into account protein-coding variant effects, we also included CoDing 313 exon Sequence (CDS) as an additional annotation (Carlson and Maintainer, 2015) 314 and observed significant enrichment for CDS in the single state results ( Figure  315 3B, Table 1 ). FGWAS multi-feature analyses for T2D, incorporating all 316 annotations positive in single-element analyses, retained both subclasses of 317 strong enhancer, the subclass of open weak enhancers, and CDS in the joint 318 model ( Figure 3C and Methods). 319
320
We observed markedly different levels of enrichment for T2D association 321
between and within open and closed enhancer states ( Figure 3B -3C, Table 1 ). 322
Using these augmented chromatin state maps, we demonstrated clear 323 enrichment for T2D association for the subset of "open" weak enhancers (12% of 324 all weak enhancer sites) with no evidence of enrichment in the remaining 325 subclasses ("closed" and "lowly-methylated") ( Figure 3B and Table 1 ). This 326 concentration of enrichment amongst a relatively small subset of the weak 327 enhancers was consistent with the lack of enrichment across all weak enhancers 328 defined solely on the basis of H3K4me1 signal ((Parker et al., 2013) , single state 329 log2FE=0.9, CI=-2.5 to 2.0, Table 1 , Supplementary Figure 1C ). We also saw 330 differences in enrichment signal between open and closed strong enhancers, 331
with the most marked enrichment amongst open strong enhancers (22% of the 332 total, Figure 3B -C, Table 1 ). This effect was particularly obvious in the joint-333 analysis (open strong enhancer joint FE=4.1, CI=3.3 to 4.8 vs. closed strong 334 enhancer joint log2FE=2.2, CI=0.03 to 3.2, Figure 3C ).
335
Hypomethylation and open chromatin are highly correlated, but the observed 336 difference in T2D enrichment between the weak enhancer states (particularly 337 between "lowly-methylated" and "open" which differ markedly with respect to 338 chromatin status) points to a primary role for open chromatin. To test this 339 further, we regenerated chromatin state maps using different subsets of the data 340 Figure 3C) . 344
345
We further evaluated the role of subclasses of DNA methylation regulatory 346 region with respect to T2D GWAS enrichment. We divided hypomethylated 347 (<60% methylated) sequence into enhancer-like LMRs (6.5% of all 348 hypomethylated sequence), promoter-like UMRs (7.5% of hypomethylated 349 sequence), as well as PMDs (61% of hypomethylated sequence). The remaining 350 25% of hypomethylated sequence did not fit any category. LMRs were 351 significantly (CI>0) enriched (log2FE=3.2, CI=2.3 to 3.9) for T2D association 352 signals consistent with their co-localisation with distal regulatory elements, and 353 displayed modestly increased enrichment compared to enhancer states derived 354 from ChIP-seq alone ( Figure 3D , Supplementary Table 1 ). In contrast, no 355 significant enrichment was found for human islet (promoter-like) UMRs 356 (log2FE=1.4, CI=-0.6 to 2.5) or PMDs (log2FE=-0.8, CI=-1.7 to -0.1). We also found 357 no evidence that recently-described regions of T2D-associated differential 358 methylation (dDMRs: derived from comparison of WGBS data from islets of 359 diabetic and non-diabetic individuals) were enriched for genome-wide T2D 360 association signals (log2FE=-24.6, CI=-44.6 to 3.7) ( Figure 3D , Supplementary 361 Table 1) . 362 363 Finally, since the hypomethylation signal for T2D enrichment was concentrated 364 in LMRs ( Figure 3D , Supplementary Table 1) We next deployed the insights from the global FGWAS enrichment analyses to 397 define the molecular mechanisms at individual T2D susceptibility loci, refining 398 13 T2D causal variant localisation using the combination of genetic data (from fine-399 mapping) and the genome-wide patterns of epigenomic enrichment. 400 401 Specifically, we applied FGWAS to the T2D DIAGRAM GWAS data (Scott et al., 402 2017 ) under the joint model ( Figure 3C ) derived from the augmented chromatin 403 state maps. We divided the genome into 2327 segments (average size 5004 SNPs 404 or 1.2Mb) and identified 51 segments significantly associated with T2D genome-405 wide (segmental FGWAS PPA >=0.9 or single variant GWAS P< 5x10 -8 , see 406
Methods for details). These corresponded to 48 known T2D associated regions 407 representing that subset of the ~120 known T2D GWAS loci which passed those 408 significance/filtering criteria in this European-only dataset. We then calculated 409 reweighted PPAs for each variant within each segment and generated 410 reweighted 99% credible sets. 411
412
Consistent with the increased T2D GWAS enrichment of states including open 413 chromatin and DNA methylation information, we found that analyses using 414 enrichments from the augmented chromatin state model (combining ChIP-seq, 415 ATAC-seq and WGBS data) were associated with smaller 99% credible sets 416 (median of 18 SNPs) than those derived from FGWAS enrichment derived from 417
ChIP-seq data alone (median 23). In parallel, the PPA for the best variant per 418 locus increased (median 0.33 vs 0.26). Individual T2D GWAS locus results are 419 shown in Figure 4A -B. This demonstrates that the inclusion of open chromatin 420 and DNA methylation in epigenome maps helps improve prioritisation of causal 421 variants at many T2D GWAS loci. 422 423 A subset of T2D GWAS signals are known to influence T2D risk through a 424 primary effect on insulin secretion, whilst others act primarily through insulin 425 resistance. We used previous categorisations of T2D GWAS loci based on the 426 patterns of association with quantitative measurements of metabolic function 427 and anthropometry (Wood et al., 2017 , Dimas et al., 2014 , to define a set of 428 15/48 loci most clearly associated with deficient insulin secretion (and therefore 429 most likely to involve islet dysfunction). At 7 of these 15 loci, we found that islet 430 "open strong enhancer" states, and to a lesser extent "open weak enhancer" and 431 14 "closed strong enhancer", captured more than 60% of the PPA (median 91%, 432 Figure 4C ). Variants in these islet enhancer subclasses also captured at least 95% 433 of the PPA at 4 T2D GWAS loci that could not be classified according to 434 physiological association data but which have been previously implicated in 435 human islet genome or functional regulation based on islet eQTL (van de Bunt et 436 al., 2015) or mQTL (Olsson et al., 2014 ) data ( Figure 4C , genes highlighted in 437 bold). In contrast, at 3/6 of the insulin resistance and all but 6 unclassified loci, 438 the PPA was mostly (>50%) attributable to other non-islet enhancer states 439 (across all insulin resistance and unclassified loci, DNA not overlapping islet 440 enhancers and defined as "Other" capture a median PPA of 67%). Thus, islet 441 regulatory annotations are particularly useful for fine-mapping T2D GWAS loci 442 that affect insulin secretion and beta-cell function. 443
444
To obtain additional evidence to support the localisation of causal variants, we 445 tested for allelic imbalance in ATAC-seq open chromatin data. We selected 43 446 variants within 27 T2D-associated GWAS segments for testing of allelic 447 imbalance on the basis of (a) a reweighted variant PPA >=10% and (b) overlap 448 with an enriched regulatory state within the FGWAS T2D joint-model ( Figure  449 4D). Of these, 16 variants (at 13 loci) had sufficient numbers of heterozygous 450 samples (>2) and ATAC_Seq read depth (depth>9 and at least 5 reads for each 451 allele). After correcting for mapping bias using WASP, we observed the strongest 452 evidence for allelic imbalance (FDR< 0.05) at 3 out of the 16 variants 453 (rs11257655 near CDC123 and CAMK1D, rs10842991 near KLHDC5 and 454 rs11708067 at ADCY5) ( "open strong enhancer" region ( Figure 5A ) and the risk allele correlates with 461 increased chromatin accessibility. The same variant is in high LD (r2=0.82) with 462 the lead variant for a cis-eQTL for CAMK1D in islets (van de Bunt et al., 2015) . In 463 experimental assays (Fogarty et al., 2014) , the T2D-risk allele has been shown to 464 15 be associated with increased CAMK1D gene expression and enhanced binding of 465 the FOXA1 and FOXA2 transcription factors. These data all point to rs11257655 466 as the causal variant at this locus. 467
468
At KLHDC5, no clear causal variant emerged based on genetic fine-mapping data 469 alone as the credible set contained 23 variants in high mutual LD (r 2 >0.8, top 470 variant PPA<5%, Figure 5B ). Of these, variants rs10771372 (genetic fine-471 mapping PPA= 5%), rs10842992 (genetic fine mapping PPA=5%) and 472 rs10842991 (genetic fine-mapping PPA=3%) overlapped "open strong 473 enhancer" regions ( Figure 5B ), such that their reweighted PPAs rose to 23% 474 (rs10771372), 22% (rs10842992) and 13% (rs10842991), respectively. We 475 observed allelic imbalance only at rs10842991 with the T2D-risk C allele 476 showing greater chromatin accessibility (binomial P=2.9x10 -4 , Table 2 ). This 477 variant further overlapped a predicted TFBS motif for PAX6 as determined by 478 the software tool FIMO (Grant et al., 2011) : the T2D-risk allele was predicted to 479 enhance PAX6 transcription factor binding consistent with the allelic effects on 480 increasing chromatin accessibility (Supplementary Figure 5A ). This strong 481 enhancer region is almost exclusively found in islets, with strong enhancer 482
H3K27ac states overlapping rs10842991 in only two non-islet (heart and 483 smooth muscle) Epigenome Roadmap tissues (out of 99 tissues with 18-state 484 chromatin state information, Figure 5B ) (Roadmap Epigenomics et al., 2015) . 485
Islet eQTL data (Varshney et al., 2017) also links rs10842991 and close proxy 486 SNPs (including rs7960190) to islet transcription with the risk allele increasing 487 KLHDC5 expression. These data prioritise rs10842991 as the likely causal 488 variant at the KLHDC5 T2D GWAS locus, and indicate a likely molecular 489 mechanism involving modified PAX6 transcription factor binding and an impact 490 on KLHDC5 expression and islet function. 491
492
The third example of allelic imbalance mapped to the ADCY5 locus. Fine-mapping 493 based solely on genetic data could not prioritise a distinct causal variant due to 494 multiple variants in high LD (range for top 5 variants=12-26%, Figure 5C ). 495
However, reweighting of variants based on epigenomic annotation clearly 496 prioritised variant rs11708067: this SNP overlapped an "open weak enhancer" 497 and captured most of the reweighted PPA (PPA=90%). Allelic imbalance analysis 498 also showed that the T2D-risk A allele was associated with decreased chromatin 499 accessibility (binomial P=2.9x10 -6 , Table 2 ). The same lead variant maps to an 500 islet cis-eQTL and methylation QTL ( Figure 5C , Supplementary Figure 5B A key challenge in the quest to describe the molecular mechanisms through 517 which GWAS signals influence traits of interest, involves the identification of the 518 causal variants responsible and, given that most lie in non-coding sequence, the 519 characterisation of the regulatory elements which they perturb. This underpins 520 efforts to define the effector genes through which these variants operate and to 521 reconstruct the biological networks that are central to disease pathogenesis. 522 523 Genetic and physiological studies have highlighted the singular importance of 524 pancreatic islet dysfunction in type 2 diabetes, but epigenomic characterisation 525 of this tissue has been limited in large-scale community projects such as ENCODE 526
and GTex. The present study seeks to address this deficit by describing, in 527 unprecedented detail, genome-wide patterns of methylation and chromatin 528 accessibility in human islet material. We have combined these data with existing 529 islet epigenomic marks to generate a refined regulatory map which, based on the 530 evidence of improved enrichment for T2D association signals, offers more 531 granular annotation of functional impact. 532 533 Our data show that, for DNA methylation, the signal of T2D predisposition is 534 primarily associated with enhancer-like LMRs rather than other categories of 535 methylation elements including UMRs, dDMRs or PMDs. We highlight the strong 536 correlation between islet methylation status and chromatin accessibility but 537 demonstrate that both genomic annotations independently contribute to 538 defining the regulatory impact associated with genetic T2D risk. Having said that, 539 comparative analyses reveal that assays of DNA accessibility capture more of 540 that genetic risk than whole genome methylation data. Finally, we demonstrate 541 how these enhanced epigenomic annotations, when analysed in concert with 542 genetic fine-mapping data and information from allelic imbalance in chromatin 543 accessibility allow us to home in on likely causal variants at T2D association 544 signals such as those near ADCY5, CDC123 and KLHDC5. 545 546 While previous studies had explored the candidacy of selected variants at the 547 CDC123 (Fogarty et al., 2014) and ADCY5 (Olsson et al., 2014 , van de Bunt et al., 548 2015 loci with respect to islet regulation and T2D predisposition, our 549 integrative analysis of T2D GWAS and epigenetic data has enabled a detailed and 550 comprehensive analysis that considers the regulatory impact of all variants at 551 these loci across multiple islet samples. Our analysis implicates the rs11257655 552 and rs11708067 variants as the most likely causal variants at the CDC123 and 553 ADCY5 loci respectively and highlights their relationship to islet enhancer 554 activity. The findings at ADCY5 are supported by a recent paper that found allelic 555 imbalance in H3K27 acetylation involving the rs11708067 variant in a single 556 human islet sample, and which observed that deletion of the relevant enhancer 557 element led to reduction in both ADCY5 gene expression and insulin secretion 558 (Roman et al., 2017) . 559 560 At the KLHDC5 locus, local LD frustrated efforts to define the causal variant using 561 genetic data alone, but the integration of genetic and epigenetic data pinpointed 562 rs10842991 as the likely culprit based on its impact on chromatin accessibility in 563 an open enhancer region. Evidence that this variant co-localises with an islet cis-564 eQTL signal points to KLHDC5 as the likely downstream target (Varshney et al., 565 2017) . Overall, our integrative approach provides useful insights into the 566 functional mechanisms through which T2D GWAS signals operate. Our findings 567 mirror those from other studies, which have, in various ways, and for other 568 complex traits, combined diverse epigenomic annotations to explore the basis of 569 genetic risk (Wang et al., 2016) . 570 571 The whole genome methylation data generated in the present study also allowed 572 us to evaluate the likely contribution of previously identified T2D-associated 573 dDMRs (Volkov et al., 2017) with respect to T2D predisposition. These dDMRs, 574 defined on the basis of observed differences in methylation between islets 575 recovered from diabetic and non-diabetic donors, cover a substantial part of the 576 genome, but we were able to show that only a small minority of these overlap 577 functional islet regulatory regions. As a consequence, dDMR regions as a whole 578 had no significant enrichment for T2D association signals. This suggests that 579 most of the dDMR signal involves stochastic effects and/or the secondary 580 consequences on methylation of the diabetic state. However, we cannot exclude 581 that some of the dDMR signals are causal contributors to the diabetic phenotype 582 either because they reflect environmental rather than genetic predisposition, or 583 because they accelerate further perturbation of islet dysfunction as diabetes 584 develops. 585
586
Although the present study characterises islet epigenome status and variability 587 in chromatin accessibility in substantially larger numbers of islet samples than 588 those previously reported (Gaulton et al., 2015b , Parker et al., 2013 , Pasquali et 589 al., 2014 , Varshney et al., 2017 , the number of islet preparations for which these 590 data were available was still limited. As a result, our power to detect allelic 591 imbalance in chromatin accessibility was restricted to sites with common 592 variants and relatively large effects. We anticipate that expansion of these 593 sample numbers will extend our capacity to detect such allelic imbalance, and 594 offer more granular insights into the relationships between genetic variation and 595 methylation status. A further limitation is that the genomic data we analysed was 596 19 generated only from islet samples from non-diabetic donors. Whilst causal 597 inference is possible through the integration of basal epigenomic annotations 598 with genetic data, addition of epigenomic data from islets recovered from 599 diabetic donors has the potential to add a further dimension to such analyses, 600
and to unravel what are likely to be complex causal relationships between 601 genetic variants, epigenomic phenotypes and disease states ( Isolation Facility and stored for 1-3 days in CMRL or UW media. The latter were 635 reactivated in CMRL for 1h before processing them further. Approximately 636 50,000 islet cells per sample were hand-picked and immediately processed for 637 ATAC-seq as described previously (Buenrostro et al., 2013) , however, an 638 additional round of purification was performed using Agencourt AMPure XP 639 magnetic beads (Beckman Coulter). System 1-8 (Nugen) and purified using Agencourt AMPure beads (Beckman 649 Coulter) as described previously (Lowe et al., 2013) . 650 651
Library generation and processing of reads 652
The libraries were sequenced by members of the High-Throughput Genomics 653 group at the Wellcome Trust Centre for Human Genetics, University of Oxford, 654
Oxford, UK. Samples were sequenced as multiplex libraries across 3 HiSeq2000 655 lanes with 100bp paired-end read length (including a PhIX spike-in of 5%) to 656 obtain high-coverage read data. The obtained reads were trimmed using a 657 customized python3 script (10bp at the start and 15bp at the end) and aligned to 658 hg19 using the software Bismark (settings: L,0,-0.6, version 0.12.5) (Krueger and 659 Andrews, 2011) . Specifically, paired-end alignment of trimmed reads was 660 performed and unmapped reads from read 1 were realigned using Bismark and 661 merged with the paired-end alignment using samtools ) (version 662 0.1.19) in order to increase mapping efficiency. Coverage for the merged paired-663 end and realigned HiSeq read alignments was estimated for the human 664 mappable genome (NCBI hg19 2.8 billion base pairs excluding gaps and 665 unmappable and blacklisted regions according to UCSC and 666 Encode(EncodeProjectConsortium, 2012)) using bedtools (version v2.21.0) 667 (Quinlan, 2014) . 668 669
WGBS DNA methylation quantification and prediction of 670 hypomethylated regulatory regions 671
CpG methylation levels were determined for each sample by calculating the ratio 672 of unmodified C (methylated) and bisulphite converted T (unmethylated) alleles 673 using BiFAST (first described here (Lowe et al., 2013) ). High-pass pooled WGBS 674 data was generated by adding methylated and unmethylated read counts across 675 22 individual low-pass samples to then estimate the average beta methylation 676 levels. 677 678 Regulatory regions were identified using the R package methylseek (Burger et 679 al., 2013) . After removing PMDs, which represent highly heterogenous 680 methylation states determined by DNA sequence features (Gaidatzis et al., 2014) , 681
LMRs (<30 CpGs) and UMRs (>30 CpGs) were predicted in hypomethylated 682 regions (<50%) at an FDR of 0.05. The methylation level and FDR parameter was 683 inferred from the data as suggested by the methylseek workflow (Burger et al., 684 2013) . 685 Open chromatin peaks were called through the aforementioned in-house 739 pipeline by applying sample-specific read depth and width parameters, which 740 were chosen based on the signal to noise ratio of a given sample. 741
ChIP-seq data and identification of chromatin states 742 743
Processing of available ChIP-seq data 744
Human islet ChIP-seq histone mark and TFBS data were obtained from various 745 sources: H3K4me1, CTCF and H3K27ac (Pasquali et al., 2014) , H3K36me3 and 746
H3K4me3 (Moran et al., 2012) and H3K27me3 (Roadmap Epigenomics et al., 747 2015) . Available raw fastq files were aligned to hg19 using bowtie1 (version 748 1.1.1) with modified default settings (-m 1 which removes reads with more than 749 1 valid alignment and -n 1 which defines the maximum number of mismatches in 750 seed) and PCR duplicates were removed from the aligned bam files with Picard 751 tools (v1.119, http://broadinstitute.github.io/picard/). The resulting reads were 752 converted into bed format using the bedtools bamToBed function (Quinlan, ChIP, ATAC-seq and DNA methylation data (ChIP+ATAC+Meth) using the 777 Learnmodel ChromHMM function ( Figure 3A and Supplementary Figure 3A-B) . 778
As suggested by (Ernst et al., 2011) , after evaluating models with up to 20 779 chromatin states, a 15 state model was chosen based on the resolution provided 780 by identified states 781 782 4.6 ADCY5 Capture C analysis and ATAC-seq in EndoC-ßH1 783
Next-generation Capture-C was performed in order to map physical chromatin 784 interactions with the ADCY5 promoter in EndoC-ßH1 cell lines (n = 3) (see 785 protocol in Methods in (Davies et al., 2016) ). 786
In brief, chromatin conformation capture (3C) libraries were generated by 787 formaldehyde fixation prior to DpnII restriction enzyme digestion and 788 subsequent DNA ligation. Following cross-link reversal, DNA extraction and 789 sonication, sequencing adapters were added to sonicated fragments (~200bp). 790
Library fragments were subjected to a double capture through hybridisation 791 with a biotinylated oligonucleotide probes encompassing the ADCY5 promoter 792 and enriched using streptavidin bead pulldown. PCR amplified fragments were 793 then sequenced through paired-end sequencing (Illumina Next-Seq). An in silico 794 restriction enzyme digestion was performed on the set of reconstructed 795 fragments (from paired-end sequenced reads) using the DpnII2E.pl script 796 (https://github. com/telenius/captureC/releases). Uncaptured reads and PCR 797 duplicates were removed prior to mapping to the human genome (hg19) with 798
Bowtie (Langmead et al., 2009) In addition, ATAC-seq was performed in 50,000 cells of EndoC-ßH1 cell lines 807 (n=3) and the data was analysed in the same way as described above for human 808 islet samples. 809 4.7 Overlaying generated epigenomic datasets generated here with other 810 genomic regulatory regions 811 812 CpG sites and/or hypomethylated regulatory regions identified from the WGBS 813 and/or 450k array data were overlapped with existing islet chromatin state 814 maps (Parker et al., 2013) , islet transcription factor binding sites (FOXA2, MAFB,  815   NKX2.2, NKX6.1, PDX1) , T2D-associated islet dDMRs (Dayeh et al., 2014) and 816 eQTLs (van de Bunt et al., 2015) . Similarly, ATAC-seq open chromatin peaks 817 generated here were overlapped with publicly available ATAC-seq peaks 818 (Varshney et al., 2017) . 819
820
In addition, we also obtained the 850k array manifest file to determine overlap 821 of 850k array CpG sites with GWAS credible set regions 822 (https://support.illumina.com/downloads/infinium-methylationepic-v1-0-823 product-files.html). 824 Furthermore, data from (Wood et al., 2017) and (Dimas et al., 2014) were used 838 to categories T2D GWAS loci into physiological groups of insulin secretion, 839 insulin resistance or unclassified loci. 840 To determine the maximum likelihood model the following approach suggested 882 by (Pickrell, 2014) was used for each set of chromatin states 883 ChIP+ATAC, ChIP+Meth and ChIP+ATAC+Meth), separately. Firstly, a model was 884 fitted for each annotation individually to identify all annotations that were 885 significantly enriched with the trait. Secondly, the annotation with the highest 886 increase (and enrichment) in the maximum log-likelihood was added to the 887 model and the analysis was repeated with the additional annotation. Thirdly, 888
annotations were added as long as they increase the maximum log-likelihood of 889 the newly tested model. Fourthly, a 10-fold cross-validation approach was used 890 after determining a penalty parameter based on the maximum likelihood of a 891 penalised log-likelihood function to avoid overfitting. Fifthly, each annotation 892 was dropped from the model and the maximum cross-validation likelihood was 893 evaluated. If a reduced model has a higher cross-validation maximum likelihood, 894 additional annotations are dropped until the model cannot be further improved. 895
This model was described as the best fitted model and used for the remaining 896 analysis. The maximum likelihood enrichment parameters and 95% CI for each 897 annotation of the best model were reported (independent of significance). 898 states) a nested model and log-likelihood ratio test were used to determine the 918 contribution of each annotation to the model (Supplementary Figure 3D) . 919 follow-up. Genome-wide significance of loci was determined based on P-values 930 (P <5x10 -8 ) or a regional FGWAS PPA >= 90% (representing the sum of the PPAs 931 of all SNPs in a given region). The latter threshold is based on a recommendation 932 from (Pickrell, 2014) who observed that a regional PPA of 90% or above can be 933 used to identify sub-threshold GWAS loci. 934
30
Of the prioritised variants, only variants with at least 2 heterozygous samples 936 and ATAC_Seq read depth of at least 9 reads (minimum 5 reads for each allele) 937 were tested for allelic imbalance. 938
939
To avoid read-mapping and reference allele bias the software WASP (van de 940 Geijn et al., 2015)(Version 0.2261) was used to remove reads associated with 941 mapping bias. In short, reads of the unfiltered bam file that overlapped the 942 variant of interest were identified. For each read overlapping an SNP, the 943 genotype of that SNP was changed to the alternative allele and the read was 944 remapped using bwa ) (version 0.5.8c). Any read that failed 945 to realign in the same position in the genome was discarded. Ultimately, PCR 946 duplicates were filtered using the WASP "rmdup_pe.py" script, which removed 947 duplicated reads randomly (independent of the mapping score) to avoid any 948 bias. 949 950 Allelic imbalance was determined using a binomial test as implemented in R. 951 All figures unless otherwise stated were generated using R (version 3.0.2) 978 and/or ggplot2 (Wickham, 2009) . Figure 1E was generated using locuszoom 979 (Pruim et al., 2010) . Chromatin state CHiP-seq enrichment maps ( Figure 3A , 980
Supplementary Figure 3A -B) were generated using chromHMM (Ernst and Kellis, 981 2012) . The genome-browser views ( Figure 5) were generated using the UCSC 982 genome browser tool (Kent et al., 2002) . 983 984
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